20240024159. POSTERIOR CHAMBER PLACEMENT OF SUSTAINED RELEASE IMPLANT simplified abstract (Allergan, Inc.)

From WikiPatents
Jump to navigation Jump to search

POSTERIOR CHAMBER PLACEMENT OF SUSTAINED RELEASE IMPLANT

Organization Name

Allergan, Inc.

Inventor(s)

Michael Robinson of Huntington Beach CA (US)

Alazar Ghebremeskel of Irvine CA (US)

Zoran Novakovic of Irvine CA (US)

David Aubuchon of Mission Viejo CA (US)

John Vanden Dries of San Clemente CA (US)

POSTERIOR CHAMBER PLACEMENT OF SUSTAINED RELEASE IMPLANT - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240024159 titled 'POSTERIOR CHAMBER PLACEMENT OF SUSTAINED RELEASE IMPLANT

Simplified Explanation

The patent application describes a system for reducing intraocular pressure in a patient. The system includes a delivery device and an intraocular implant positioned within the lumen of a cannula, proximal to a retention plug. The delivery device has a housing that can be held by an operator and an actuator. The cannula, which is attached to the housing, defines a lumen and extends from a proximal end to a distal end. The distal end of the cannula has rounded inner and outer edges, creating a blunt, non-beveled distal opening from the lumen. The retention plug is attached to the cannula near the distal opening.

  • The system includes a delivery device and an intraocular implant.
  • The delivery device has a housing and an actuator.
  • The cannula, attached to the housing, has a lumen and extends from a proximal end to a distal end.
  • The distal end of the cannula has a blunt, non-beveled opening from the lumen.
  • The retention plug is attached to the cannula near the distal opening.

Potential applications of this technology:

  • Treatment of patients with elevated intraocular pressure.
  • Management of glaucoma.
  • Reduction of the risk of optic nerve damage.

Problems solved by this technology:

  • High intraocular pressure can lead to various eye conditions, including glaucoma.
  • Existing treatment methods may have limitations or side effects.
  • This system provides a more controlled and targeted approach to reducing intraocular pressure.

Benefits of this technology:

  • Improved accuracy and precision in reducing intraocular pressure.
  • Minimized risk of complications or damage to the eye.
  • Enhanced patient comfort and convenience during the procedure.


Original Abstract Submitted

a system for reducing intraocular pressure of a patient in need including a delivery device and an intraocular implant positioned within the lumen of the cannula proximal to a retention plug. the delivery device has a housing sized to be held by an operator and an actuator. the delivery device has a cannula defining a lumen and having a proximal end coupled to the housing. the cannula extends along longitudinal axis from the proximal end to a distal end, the distal end of the cannula having rounded inner and outer edges defining a blunt, non-beveled distal opening from the lumen. the retention plug is attached to the cannula spanning the lumen near the distal opening. related methods, implants and delivery tools are provided.

Retrieved from "http://wikipatents.org/index.php?title=20240024159._POSTERIOR_CHAMBER_PLACEMENT_OF_SUSTAINED_RELEASE_IMPLANT_simplified_abstract_(Allergan,_Inc.)&oldid=29436"